Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-ablation Inflammatory Response and Endothelial Function in the Development of Early Recurrence of Atrial Tachyarrhythmia After Pulmonary Vein Isolation; Implications for Pulmonary Vein Reconnection and Freedom From Atrial Fibrillation

NCT04269785 is registered in ClinicalTrials.gov with Karan Saraf as lead sponsor.

NCT NCT04269785
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269785 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-ablation Inflammatory Response and Endothelial Function in the Development of Early Recurrence of Atrial Tachyarrhythmia After Pulmonary Vein Isolation; Implications for Pulmonary Vein Reconnection and Freedom From Atrial Fibrillation
Lead sponsor
Karan Saraf
Phase
Not applicable
Overall status
Withdrawn
Start date
January 30, 2023
Completion date
June 1, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation, persistent atrial fibrillation